* Aethlon Medical Inc is expected to show a fall in quarterly revenue when it reports results on June 27 for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Aethlon Medical Inc is for a loss of $1.23 per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Aethlon Medical Inc is $6.75, above its last closing price of $0.60.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -1.23 -1.23 -1.37 Missed -11.4
Jan. 1 2023 -1.30 -1.40 -1.22 Beat 12.9
Jun. 30 2023 -1.20 -1.30 -1.40 Missed -7.7
Mar. 31 2023 -1.30 -1.00 Beat 23.1
Dec. -0.81 -0.80 -1.20 Missed -50
31 2022
Sep. 30 2022 -2.15 -1.80 Beat 16.3
Jun. 30 2022 -2.16 -2.20 -1.90 Beat 13.6
Mar. 31 2022 -1.40 -2.60 Missed -85.7
This summary was machine generated June 24 at 21:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments